Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
AMIRAVOResearch Library
Cycle-length evidence

DSIP cycle length: what human studies ran

Not approved — research use onlyBLimited human data
Short answer: there is no established DSIP cycle length, and we found no human studies that report one.

Treatment and follow-up in human studies

No human study durations are recorded.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • DSIP combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established DSIP cycle length?
No. We found no human studies that report a treatment duration for DSIP.
What is the longest human study of DSIP?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
DSIP dosing reference Full research page

References

  1. Drugs@FDA application data queried through openFDA for emideltide and delta sleep-inducing peptide (no matching application record returned on 22 October 2026) openFDA / Drugs@FDA. 2026
  2. July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee (agenda, questions and briefing documents) FDA Advisory Committee Calendar. 2026
  3. FDA Briefing Document, Pharmacy Compounding Advisory Committee Meeting, July 23-24, 2026 (covering BPC-157-, KPV-, TB-500-, MOTS-c-, Emideltide-, Epitalon- and Semax-related bulk drug substances) FDA. 2026
  4. International Standard: Prohibited List 2026 World Anti-Doping Agency. 2026
  5. Delta sleep-inducing peptide (DSIP): a still unresolved riddle J Neurochem. 2006
  6. Delta-sleep-inducing peptide (DSIP): an update Peptides. 1986
  7. Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia Eur Neurol. 1987
  8. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study Neuropsychobiology. 1992
  9. PubChem compound record for delta sleep-inducing peptide (CID 68816; CAS 62568-57-4) PubChem. 2026